Page last updated: 2024-08-17

hydroxyproline and perindopril

hydroxyproline has been researched along with perindopril in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukui, H; Ikenaka, Y; Kitade, M; Kuriyama, S; Namisaki, T; Noguchi, R; Tsujinoue, H; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H	1
Al-Ismaeel, H; Al-Rikabi, AC; Al-Shabanah, OA; Mansour, MA	1

Other Studies

2 other study(ies) available for hydroxyproline and perindopril

Article	Year
Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development. Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:1 Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cell Proliferation; Collagen Type I; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hydroxyproline; Interferon-beta; Kupffer Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred BALB C; Perindopril; Rats; Rats, Inbred F344; RNA, Messenger; Tetrazoles	2005
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver. Life sciences, 2011, Aug-01, Volume: 89, Issue:5-6 Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A	2011

Article

Year

Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.

Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:1

Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cell Proliferation; Collagen Type I; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hydroxyproline; Interferon-beta; Kupffer Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred BALB C; Perindopril; Rats; Rats, Inbred F344; RNA, Messenger; Tetrazoles

2005

Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.

Life sciences, 2011, Aug-01, Volume: 89, Issue:5-6

Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A

2011